CorePlus

Name

CorePlus

Legal name

CorePlus Servicios Clínicos y Patológicos, LLC

Website

https://corepluspr.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Headquarters

HQ city

San Juan

HQ country

Puerto Rico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services - Direct-to-Consumer: CorePlus generates revenue through laboratory testing services paid by patients directly (direct-to-consumer model), healthcare professionals ordering tests for patients, and businesses for employee wellness programs and drug testing services. The company operates a retail online shop where consumers can purchase individual lab tests without physician orders.
2. Individual Lab Test Sales:
3. Business/Corporate Testing Services: Corporate wellness programs providing ongoing employee testing services, urine drug testing for employers, and specialized services like ElderPlus for nursing homes and FoodSense+ testing programs for businesses.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

CorePlus is a precision pathology laboratory providing AI-enabled anatomic and clinical pathology, cytopathology, fine needle aspiration biopsies, molecular and infectious disease diagnostics, wellness panels, food sensitivity testing (FoodSense+), urine drug testing, and elder-care clinical services. It deploys whole slide imaging integrated with partner AI engines (Ibex Galen, Techcyte SureView, AIxMed AIxURO, Alpenglow 3Deep Imager) to support primary cancer diagnosis and 100% quality control of cytology slides, and sells these services through a direct-to-consumer online shop, a healthcare-professional reference channel, and a corporate/B2B sales channel in Puerto Rico.

Product overview

CorePlus is a precision pathology laboratory offering a comprehensive portfolio of diagnostic services centered around AI-powered digital pathology. The core offering is AI-enabled anatomic and clinical pathology services, which they differentiate through integration with third-party AI platforms including Techcyte SureView for cervical cytology QC, AIxMed AIxURO for bladder cancer detection, Ibex Galen for cancer diagnosis, and Alpenglow 3D imaging for prostate biopsies. Supporting the core pathology services are specialized testing modules including FoodSense+ (food sensitivity testing), Wellness+ (health and metabolic panels), Urine Drug Testing+ (3-12 panel options), ElderPlus (nursing home services), molecular testing, and infectious disease screening. The company also offers a direct-to-consumer WeCARE mobile app for test registration and results access. All services are delivered through their two laboratory locations in Puerto Rico (Carolina and Ponce) with online appointment booking.

Differentiator

Problem solved

Functional benefit

Brands

• WeCARE: Mobile application for patients to access lab services, track specimen status, and receive results.
• FoodSense+
• Wellness+
• ElderPlus
• Urine Drug Testing+
• AIxURO
• RESPIRA5+
• Techcyte SureView

Products and services

• AI-Powered Digital Pathology AI-enabled anatomic and clinical pathology laboratory testing that supports primary cancer diagnosis. CorePlus is the first independent lab in the Americas to implement AI for primary diagnosis using digital pathology with the Ibex Galen platform, and integrates Techcyte SureView for cervical cytology, AIxMed AIxURO for bladder cancer detection, and Alpenglow 3Deep Imager for prostate biopsy 3D imaging. Customers: referring physicians and healthcare professionals.
• Pathology Services Anatomic pathology services for diagnosing and treating tumors, skin infections, nerve conditions, and other conditions. Includes precision medicine and digital pathology workflows for rapid and accurate diagnosis. Customers: referring physicians and healthcare professionals.
• Cytopathology Specialized cytopathology tests across women's health and oncology, supported by AI-quality-control platforms (AIxURO for bladder cancer detection, Techcyte SureView for cervical cytology). Customers: referring physicians and patients.
• FoodSense+ Food Sensitivity Test Food sensitivity test evaluating IgG immunological reactivity to 108 foods (chicken, eggs, milk, meats, cereals, legumes, nuts, fruits, vegetables, fish, seafood) using dry blood spot sample collection. Available direct-to-consumer and as a corporate wellness offering.
• Urine Drug Testing+ (3, 5, 6, 10, 12 Panels) Advanced urine drug testing using a chemistry analyzer with EIA technology and specimen validity testing (pH, specific gravity, creatinine). Tests for cocaine, amphetamines, opiates, PCP, methadone, benzodiazepines, heroin, barbiturates, methamphetamines, THC, buprenorphine, and oxycodone. Customers: employers and occupational health programs.
• Wellness+ Testing Panels Wellness testing panels covering diabetes (A1C, glucose), vitamin (D, B12), anemia (folate, ferritin), thyroid (TSH, T3 uptake, Free T4, TPO antibodies), heart health (cholesterol, LDL, HDL, triglycerides), and comprehensive metabolic panels. Customers: direct-to-consumer patients and corporate wellness programs.
• FNA (Fine Needle Aspiration) Biopsies Advanced fine needle aspiration biopsy procedures to detect complex malignant and benign conditions, including thyroid FNA biopsies. Customers: referring physicians and patients.
• ElderPlus Nursing Home Clinical Services Clinical laboratory services delivered to nursing homes with daily actionable tests, compliance with screening tests (HbA1C, PSA, CMP, BMP, Vitamin D, Lipid Panel), and direct assistance with care coordination. Customers: nursing homes and long-term care facilities.
• Molecular Testing Molecular testing using advanced technology to study genetic makeup for accurate diagnosis and monitoring of illnesses (including MycoSure+ PCR for Mycoplasma pneumoniae). Customers: referring physicians and patients.
• Infectious Disease Testing Precision-driven laboratory tests for detecting a wide range of infectious diseases including STIs (HIV, chlamydia, gonorrhea, syphilis, herpes), COVID-19 PCR and rapid antigen, influenza A/B, Mycoplasma pneumoniae, and respiratory pathogens (RESPIRA5+ panel). Customers: direct-to-consumer patients, healthcare professionals, and businesses.
• Clinical+ Laboratory Services Advanced clinical laboratory methods for diagnosing diverse clinical samples as part of CorePlus's comprehensive clinical laboratory service. Customers: patients, healthcare professionals, and businesses.
• WeCARE Mobile App Mobile application for iOS and Android that enables clients to register test kits, track specimen status, and receive results electronically. Customers: direct-to-consumer patients and clinical clients.

Quantifiable outcome

• Reduced diagnostic review time by 50-80% while maintaining consistent accuracy and reproducibility
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• IbexcoreTechnology or Integration · 25 March 2026CorePlus and Ibex expanded their partnership to include clinical deployment of AI-powered diagnostics for transurethral resection of the prostate (TURP). The collaboration focuses on integrating AI technology to improve diagnostic accuracy in clinical settings. Previously, CorePlus used Ibex's Galen platform to diagnose over 10,000 patients with AI assistance for routine cancer diagnosis.
• AIxMedcoreTechnology or Integration · 7 January 2026CorePlus implemented AIxURO, an AI-powered software solution for bladder cancer detection through improved urine cytology analysis. The platform analyzes whole slide images and presents abnormal cells following The Paris System diagnostic standards, reducing diagnostic review time by 50-80%. The collaboration represents over two years of dedicated development and innovation.
• RCM&DminorGTM or Marketing Partner · 23 October 2025Strategic partnership to launch an exclusive cyber insurance program that rewards proactive cybersecurity measures. The program aims to improve underwriting outcomes and provide cost savings and coverage enhancements to organizations utilizing CorePLUS's cybersecurity solutions.
• TechcytecoreTechnology or Integration · 1 January 2025CorePlus deployed Techcyte's AI algorithm for 100% quality control of all cytology slides. The validation study achieved 97% accuracy, 82% sensitivity, 99% specificity, and 98% negative predictive value, outperforming traditional dry scanning and light microscopy while reducing scan time by 66% and review time by 62%.
• Alpenglow BiosciencescoreStrategic or Co-development Partner · 1 January 2024Partnership for development and implementation of 3D imaging technology enabled with AI. CorePlus will employ 3D images of prostate biopsies to train AI models to recognize key tissue structures such as cancer cells, immune cells, and blood vessels in a CLIA environment using the 3Deep Imager solution.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: One of the largest U.S. clinical reference labs, offering routine and specialty diagnostics including anatomic pathology. Directly comparable as a pathology and clinical laboratory operator with national scale, though CorePlus is differentiated by its AI-first primary diagnosis approach and DTC channel.
• Sonic Healthcare: Global pathology and clinical lab operator with significant anatomic pathology exposure in the U.S. (e.g., Sonic Healthcare USA). Comparable as a multi-region pathology services platform, though at much larger scale than CorePlus's Puerto Rico footprint.
• Hologic: Women's health diagnostics company with cytology and molecular testing products (ThinPrep, NovaSure). Comparable in the cervical cytology and women's health screening spaces where CorePlus deploys the Techcyte SureView system.
• Labcorp: Major U.S. clinical and anatomic pathology lab with national footprint and broad test menu including women's health, oncology, and molecular diagnostics. Comparable as a full-service reference lab competing for the same physician referral base CorePlus serves.

Direct peers

• BioReference Laboratories: U.S. clinical and anatomic pathology reference laboratory offering specialized oncology, women's health, and urology diagnostics. Closely comparable as a specialty pathology lab serving physician referrals and direct consumers, overlapping strongly with CorePlus's test menu and customer base.
• NeoGenomics: Specialized oncology reference laboratory providing cancer-focused molecular and anatomic pathology services. Closely comparable as a specialty oncology pathology operator targeting oncologists and urologists, overlapping with CorePlus's urologic pathology practice.

Emerging players

• PathAI: AI pathology platform developing diagnostic and biomarker-discovery tools for cancer and other diseases. Comparable as a digital pathology AI specialist, though PathAI focuses on platform/biomarker sales versus CorePlus's service-delivery model.
• Akoya Biosciences: Digital spatial profiling and multiplexed tissue imaging company serving pathology and immunology research. Comparable as a digital pathology technology provider, though Akoya sits upstream as a tools vendor rather than a service competitor like CorePlus.
• Ibex Medical Analytics: AI-powered cancer diagnostics platform whose Galen product CorePlus deploys for primary diagnosis. Closely tied as a technology partner and a direct competitor for AI pathology contracts with other labs; overlapping product offering with CorePlus's AI-enabled cancer diagnosis.
• Techcyte: AI-driven digital cytology platform whose SureView cervical cytology QC system CorePlus deployed. Partner-and-competitor hybrid: Techcyte's platform enables CorePlus's 100% QC while also selling direct to other cytology labs.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/corepluspr

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorePlus